BioDulse II: The Effect of an Irish Seaweed Protein Extract on Glucose Control in Adults With Type 2 Diabetes

Last updated: April 8, 2024
Sponsor: University of Limerick
Overall Status: Active - Not Recruiting

Phase

N/A

Condition

Diabetes Mellitus, Type 2

Diabetes And Hypertension

Diabetes Prevention

Treatment

Maltodextrin

Seaweed protein

Clinical Study ID

NCT05986253
23_05_07_EHS
  • Ages 18-67
  • All Genders

Study Summary

Co-ingesting protein with carbohydrate is an effective way to improve postprandial glucose handling. The investigators have isolated and identified a bioactive protein extracted from seaweed. The investigators aim to explore how varying doses of seaweed protein influence postprandial glycaemia and insulinaemia in a population with type 2 diabetes.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Aged 18-67

Exclusion

Exclusion Criteria:

  • Terminal disease
  • Exclusively receiving enteral or parenteral nutrition
  • Any conditions/anomalies that are contraindications to bioelectrical impedanceanalysis as per institutional risk assessment and standard operating procedures
  • Past medical history of cancer, neurological, kidney, pulmonary, digestive (Coeliacdisease), thyroidal disease, cognitive impairment

Study Design

Total Participants: 10
Treatment Group(s): 2
Primary Treatment: Maltodextrin
Phase:
Study Start date:
August 07, 2023
Estimated Completion Date:
December 31, 2031

Connect with a study center

  • University of Limerick

    Limerick, V94 T9PX
    Ireland

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.